BVD

The World Market for Veterinary Diagnostics, 7th Edition - ResearchAndMarkets.com

Retrieved on: 
Tuesday, February 6, 2024
Veterinary, Health, Seventh Edition, Row, PRRS, Infection, Betaarterivirus suid 1, BVD, Clinical chemistry, Bovine viral diarrhea, Animal, IVD, Classical swine fever, TGE, Pet, Vaccine

The "World Market for Veterinary Diagnostics, 7th Edition" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "World Market for Veterinary Diagnostics, 7th Edition" report has been added to ResearchAndMarkets.com's offering.
  • Despite various challenges, the veterinary diagnostics market has shown consistent growth and is forecasted to continue on this trajectory.
  • The World Market for Veterinary Diagnostics, 7th Edition meticulously examines the global veterinary diagnostics market, focusing on two key components: companion animal (pets) diagnostics and food animal diagnostics.
  • The report provides a comprehensive analysis of major veterinary disease markets, offering insights into overall market performance and development.

BioMed Valley Discoveries Announces First Patient Dosed in Phase II Combination Trial with Ulixertinib (BVD-523), its First-in-Class and Best-in-Class ERK Inhibitor, in Combination with Hydroxychloroquine

Retrieved on: 
Monday, September 12, 2022
Institute, Stowers Institute for Medical Research, MAPK, Autophagy, Phase, American Century, Neoplasm, Century, University, Investment, BRAF, Hydroxychloroquine, ERK2, Survival, ERK, Patient, Clinical trial, BVD, Huntsman Cancer Institute, Medical research, Tumor microenvironment, HCQ, ERK1, American Century Companies, Mutation, Pharmaceutical industry

KANSAS CITY, Mo., Sept. 12, 2022 /PRNewswire/ -- BioMed Valley Discoveries (BVD) announced that the first patient has been dosed in a phase II clinical trial of ulixertinib (BVD-523) in combination with hydroxychloroquine (HCQ).

Key Points: 
  • KANSAS CITY, Mo., Sept. 12, 2022 /PRNewswire/ -- BioMed Valley Discoveries (BVD) announced that the first patient has been dosed in a phase II clinical trial of ulixertinib (BVD-523) in combination with hydroxychloroquine (HCQ).
  • Ulixertinib is a first-in-class and best-in-class ERK inhibitor, with this clinical trial focusing on patients with advanced gastrointestinal malignancies and mutations in the MAPK pathway.
  • Previous efforts have also established a recommended phase 2 dose in combination with palbociclib, with additional combination efforts ongoing.
  • About BioMed Valley Discoveries (BVD): BioMed Valley Discoveries is a clinical stage biotechnology company focused on addressing unmet medical needs in a variety of therapeutic and diagnostic areas.

$2.02 Billion Livestock Diagnostics Markets, 2028 by Product (Consumables, System, Software), Technology (Immunodiagnostics, Molecular diagnostics), Animal Type (Bovine, Swine, Poultry) - ResearchAndMarkets.com

Retrieved on: 
Friday, March 11, 2022
Agriculture, Natural Resources, Point-of-care testing, Livestock, PCR, POC, ELISA, Prevalence, Consumables, BVD, Foot, Growth, Disease, CAGR, Veterinarian, Awareness, Diagnosis, Vaccine, Agriculture, Poultry, Technology, Software, Domestic pig

In addition, emerging markets are expected to offer significant growth opportunities for players operating in the livestock diagnostics market.

Key Points: 
  • In addition, emerging markets are expected to offer significant growth opportunities for players operating in the livestock diagnostics market.
  • Based on product, the livestock diagnostics market is segmented into consumables, systems, software.
  • In 2021, the consumables segment accounted for the largest share of the livestock diagnostics market.
  • Based on technology, the immunodiagnostics segment accounted for the largest share of the global livestock diagnostics market in 2021.

The World Market for Veterinary Diagnostics 2021-2026: Featuring Key Players IDEXX, Thermo Fisher Scientific, Heska Corporation and Zoetis - ResearchAndMarkets.com

Retrieved on: 
Monday, March 7, 2022
Pets, Consumer, TGE, Betaarterivirus suid 1, Infection, Classical swine fever, Journal of Veterinary Diagnostic Investigation, Country, Magic: The Gathering core sets, 1993–2007, PRRS, Severe acute respiratory syndrome, Immunoassay, BVD, Molecular diagnostics, Row, Bovine viral diarrhea, Transmissible spongiform encephalopathy, Clinical chemistry, Companion, Vaccine, Medical device, Pet, Hematology, Growth, Food Animal Concerns Trust

The "The World Market for Veterinary Diagnostics, 5th Edition " report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "The World Market for Veterinary Diagnostics, 5th Edition " report has been added to ResearchAndMarkets.com's offering.
  • The World Market for Veterinary Diagnostics, 5th Edition examines the worldwide veterinary diagnostics market through the performance of its two component markets of companion animal and food animal diagnostics.
  • The report provides an analysis of major veterinary disease markets as well as overall market performance and development.
  • Total Global Animal Diagnostic Testing Market, 2021-2026 (in millions $ at manufacturer level)
    Global Veterinary Diagnostic Testing Market Share by Region (%) 2021 (US, Europe, Asia Pacific, RoW)
    Food Animal Diagnostics Market by Infectious Disease (Bovine Viral Diarrhea [BVD], Classical Swine Fever [CSF], Enzootic Bovine Leukosis [EBL], Infectious Bovine Tracheitis [IBR], Porcine Coronavirus Diseases [PEDv, PDCoV, TGE], Porcine Reproductive and Respiratory Syndrome [PRRS], Pseudorabies/Aujeszky's, Transmissible Spongiform Encephalopathies [TSEs], Other) (% and $ millions) 2021
    The World Market for Veterinary Diagnostics, 5th Edition contains the following market data points for both the food animal and companion animal segments:
    Global Animal Diagnostic Testing Market by Animal Segment, 2021-2026 (in millions $ at manufacturer level)
    Veterinary Companion Diagnostics Market Segmentation 2021 (Companion Animal: Clinical Chemistry, Infectious disease, Hematology, Other Analyzers, Non-infect Immunodiagnostics, Molecular, Other Testing, Total; Food Animal: Immunodiagnostic Test Kits, Molecular Diagnostics, Clinical Chemistry, Other Infectious Disease Test Reagents, Total) ($million; %)
    Market Size and Growth for United States Diagnostic Testing Market, 2021-2026 ($millions)
    Market Size and Growth for European Diagnostics Testing Market, 2021-2026 ($millions)
    Market Size and Growth for Asia Pacific Diagnostic Testing Market, 2021-2026 ($millions)
    Asia Pacific Diagnostic Testing by Country Percent 2018 (Japan, Philippines, China, India, Others)
    Market Size and Growth for Rest of World Diagnostic Testing Market, 2021-2026 ($millions)
    RoW Companion Animal Diagnostic Testing by Country Percent 2021 (Companion Animal: Canada, Australia, Brazil, Mexico, Others; Food Animal: Canada, Brazil, Mexico, Others)